BioSyent to Present at Upcoming Investor Conferences

TORONTO, ONTARIO--(Marketwired - April 6, 2016) - BioSyent Inc. ("BioSyent")(TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that it will be presenting at the following upcoming investor conferences:

April 7, 2016 - Laurentian Bank Securities Annual Institutional Investor Conference at the Sofitel Hotel, Montreal, Quebec. Mr. René Goehrum, BioSyent's President and CEO, will be participating in a healthcare panel entitled "Specialty Pharmaceuticals - Continuing Success in Challenging Markets". Mr. Goehrum will also be meeting with investors on a one-on-one basis at this conference.

April 11-12, 2016 - The MicroCap Conference at the Hilton Hotel, Toronto, Ontario. Mr. Joost van der Mark, BioSyent's Vice President of Corporate Development, will present to investors an overview of BioSyent and its corporate activities. Mr. van der Mark will also be meeting with investors on a one-on-one basis.

May 2-3, 2016 - Bloom Burton & Co. Healthcare Investor Conference at the Sheraton Centre, Toronto, Ontario. Mr. René Goehrum will present to investors an overview of BioSyent's business. Mr. Goehrum will also be available to meet with investors on a one-on-one basis.

About BioSyent Inc.

Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, hospital and international business units.

As of the date of this press release, the Company has 14,021,195 shares issued and outstanding.

For a direct market quote (15 minutes delay) for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.